BioSpace News Archive

RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, reported financial results for the three months and fiscal year ended December 31, 2021.

Alaunos Therapeutics, Inc. announced that the Company’s Chief Executive Officer, Kevin S. Boyle Sr., and Vice President of Research & Development, Drew Deniger, are scheduled to participate in the Oppenheimer 32nd Annual Healthcare Conference on Thursday, March 17, 2022 at 9:20am ET.

Paratek Pharmaceuticals, Inc. announced the publication of data from an investigator-initiated study evaluating the activity of NUZYRA® in a dynamic hollow fiber model of Mycobacterium avium complex pulmonary infection.

Minerva Surgical, Inc., a woman’s health company focused on the treatment of Abnormal Uterine Bleeding, reported fourth quarter and full-year financial results for the period ended December 31, 2021.

Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, reported financial results for its fourth quarter and full year ended December 31, 2021.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that the company will present at two upcoming investor conferences.

Accelerate Diagnostics, Inc. announced financial results for the fourth quarter and full year ended December 31, 2021.

Dynavax Technologies Corporation reported that it has granted nonstatutory stock options to purchase an aggregate of 33,250 shares of Dynavax common stock and restricted stock units covering an aggregate of 48,250 shares of Dynavax common stock as inducements to 1 newly-hired employee in connection with commencement of employment with the Company.

Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, reported financial results for the quarter and twelve months ended December 31, 2021.

Varex Imaging Corporation announced that it is scheduled to present at Oppenheimer’s 32nd Annual Healthcare virtual investor conference.